GHK-Cu GHK-Cu is a tripeptide (glycyl-L-histidyl-L-lysine) copper complex occurring in human bodily fluids and believed to act as a repair signal
Understanding these requirements prevents medication degradation and ensures you receive the full therapeutic benefit of your treatment
While both fall under the broader category of peptide therapies, they serve very different purposes
Readout expected Q2 to Q3 2026
Uses & Indication Overweight or obesity (BMI above 25) Visceral and abdominal fat reduction Metabolic slowdown associated with aging Enhancing fat loss while maintaining muscle mass Suitable for patients who cannot tolerate stimulant-based weight loss medications Can be used alongside GLP-1 medications but does not replace them Benefits Increases fat breakdown through lipolysis activation Reduces new fat formation Targets stubborn adipose tissue Does not affect blood sugar or IGF-1 levels Safe metabolic profile suitable for long-term use Supports gradual and steady fat loss Dosage & Injection Protocol Standard Dosing 500 mcg subcutaneously once daily Administer in the morning while fasting or before bed Avoid injecting within 2 hours of meals, especially carbohydrate-heavy meals Injection Timing Rules Local injection site irritation (improves with rotation) Mild headache Slight increase in hunger Temporary fatigue Get in Touch Contact Us To Get Better Information
Still, research shows that B12 directly affects osteoblast proliferation and formation, and a B12 deficiency can increase osteoclast activity, potentially through its impact on increasing methylmalonic acid (MMA) and homocysteine levels
